FDA and Children's Hospitals Are Driving a New Era of Pediatric Medical Device Innovation

Why Are Pediatric Medical Devices So Hard to Develop?

Children are not simply small adults. Their anatomy changes rapidly with growth, meaning a device that fits a toddler may be useless within months. This creates unique engineering challenges — devices must either adapt to changing body sizes or be available in multiple configurations. Combined with the relatively small market compared to adult medicine, many manufacturers have historically avoided pediatric-specific development altogether.

The result has been a longstanding gap in which clinicians must improvise, using adult devices off-label or modifying them at the bedside. The FDA has acknowledged this disparity, noting that children have historically had access to fewer approved medical devices than adults. Programs like the Pediatric Device Consortia (PDC) grant program, established under the Pediatric Medical Device Safety and Improvement Act of 2007, were created specifically to address this shortfall by funding nonprofit consortia that help innovators navigate the path from concept to FDA clearance.

How Are FDA Programs Helping Close the Pediatric Device Gap?

The FDA has created several mechanisms to incentivize pediatric device innovation. The Humanitarian Device Exemption (HDE) pathway allows devices targeting conditions affecting fewer than 8,000 patients per year in the United States to reach market without the large clinical trials typically required — a critical provision given that many pediatric conditions fall well below standard commercial viability thresholds. The Pediatric Device Consortia program has funded multiple centers across the country, connecting engineers, clinicians, and entrepreneurs to move promising concepts forward.

Children's hospitals themselves have become major drivers of innovation. Institutions such as Boston Children's Hospital, Children's National in Washington, D.C., and the Children's Hospital of Philadelphia have established dedicated innovation labs and technology transfer programs. These hospital-based teams have a distinct advantage: they work directly with the patients and clinicians who understand the unmet needs most intimately. From 3D-printed airway splints to miniaturized cardiac devices, many of the most impactful pediatric technologies have originated within hospital walls rather than traditional device companies.

What Pediatric Devices Are Making the Biggest Impact Today?

One of the most celebrated recent successes is the development of smaller ventricular assist devices (VADs) for children with heart failure. For years, the only mechanical heart support options available were adult-sized pumps that could not safely be implanted in small children. The Berlin Heart EXCOR, a pediatric VAD approved through the HDE pathway, represented a landmark achievement, providing a bridge to transplant for children who previously had no options. More recently, further miniaturization efforts have expanded the range of patients who can benefit.

Beyond cardiac devices, pediatric innovation is advancing across specialties. Growth-friendly spinal implants that lengthen as a child grows — avoiding repeated surgeries — represent a paradigm shift in pediatric orthopedics. Cochlear implant systems have been refined for smaller anatomies, and advances in biocompatible materials are enabling longer device lifespans in growing bodies. Experts emphasize that sustained federal funding and hospital-industry partnerships will be essential to maintaining this momentum and ensuring that the next generation of children benefits from devices designed specifically for them.